99 related articles for article (PubMed ID: 18472419)
21. Two distinct local relapse subtypes in invasive breast cancer: effect on their prognostic impact.
Casalini P; Carcangiu ML; Tammi R; Auvinen P; Kosma VM; Valagussa P; Greco M; Balsari A; Ménard S; Tagliabue E
Clin Cancer Res; 2008 Jan; 14(1):25-31. PubMed ID: 18172248
[TBL] [Abstract][Full Text] [Related]
22. Breast cancer with synchronous metastases: survival impact of exclusive locoregional radiotherapy.
Le Scodan R; Stevens D; Brain E; Floiras JL; Cohen-Solal C; De La Lande B; Tubiana-Hulin M; Yacoub S; Gutierrez M; Ali D; Gardner M; Moisson P; Villette S; Lerebours F; Munck JN; Labib A
J Clin Oncol; 2009 Mar; 27(9):1375-81. PubMed ID: 19204198
[TBL] [Abstract][Full Text] [Related]
23. [Prognosis of local recurrence of breast cancer in Tunisia].
Sahraoui W; Essafi A; Laajili H; Haouas N; Hmissa S; Sebri L; Hraiech S; Bibi M; Bouaouina N; Ben Ahmed S; Khairi H
Tunis Med; 2006 Feb; 84(2):97-102. PubMed ID: 16755973
[TBL] [Abstract][Full Text] [Related]
24. Prognostic factors in stage-i (T1N0) breast carcinoma patients: who needs adjuvant systemic treatment?
Yildirim E; Berberoglu U
Neoplasma; 2007; 54(4):353-8. PubMed ID: 17822326
[TBL] [Abstract][Full Text] [Related]
25. Impact of primary local treatment on the development of distant metastases or death through locoregional recurrence in young breast cancer patients.
Bantema-Joppe EJ; van den Heuvel ER; de Munck L; de Bock GH; Smit WG; Timmer PR; Dolsma WV; Jansen L; Schröder CP; Siesling S; Langendijk JA; Maduro JH
Breast Cancer Res Treat; 2013 Aug; 140(3):577-85. PubMed ID: 23912958
[TBL] [Abstract][Full Text] [Related]
26. Microsatellite instability and DNA ploidy in colorectal cancer: potential implications for patients undergoing systematic surveillance after resection.
Søreide K; Slewa A; Stokkeland PJ; van Diermen B; Janssen EA; Søreide JA; Baak JP; Kørner H
Cancer; 2009 Jan; 115(2):271-82. PubMed ID: 19109816
[TBL] [Abstract][Full Text] [Related]
27. The predictors of local recurrence after radical cystectomy in patients with invasive bladder cancer.
Ide H; Kikuchi E; Miyajima A; Nakagawa K; Ohigashi T; Nakashima J; Oya M
Jpn J Clin Oncol; 2008 May; 38(5):360-4. PubMed ID: 18490370
[TBL] [Abstract][Full Text] [Related]
28. Factors predicting in-breast tumor recurrence after breast-conserving surgery.
Mechera R; Viehl CT; Oertli D
Breast Cancer Res Treat; 2009 Jul; 116(1):171-7. PubMed ID: 18815880
[TBL] [Abstract][Full Text] [Related]
29. Mucinous breast carcinoma: a large contemporary series.
Barkley CR; Ligibel JA; Wong JS; Lipsitz S; Smith BL; Golshan M
Am J Surg; 2008 Oct; 196(4):549-51. PubMed ID: 18809061
[TBL] [Abstract][Full Text] [Related]
30. Endometrioid uterine cancer: histopathological risk factors of local and distant recurrence.
Fujimoto T; Nanjyo H; Fukuda J; Nakamura A; Mizunuma H; Yaegashi N; Sugiyama T; Kurachi H; Sato A; Tanaka T
Gynecol Oncol; 2009 Feb; 112(2):342-7. PubMed ID: 19062082
[TBL] [Abstract][Full Text] [Related]
31. Malignant phyllodes tumor of the breast: local control rates with surgery alone.
Pezner RD; Schultheiss TE; Paz IB
Int J Radiat Oncol Biol Phys; 2008 Jul; 71(3):710-3. PubMed ID: 18234448
[TBL] [Abstract][Full Text] [Related]
32. [Risk of locally-advanced recurrences of breast cancer following organ-saving surgery].
Gurbanov SS; Matsko DE; Kanaev SV; Semiglazov VF
Vopr Onkol; 2009; 55(1):33-7. PubMed ID: 19435196
[TBL] [Abstract][Full Text] [Related]
33. Regional nodal recurrence after breast conservation treatment with radiotherapy for women with early-stage breast carcinoma.
Lukens JN; Vapiwala N; Hwang WT; Solin LJ
Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1475-81. PubMed ID: 19004570
[TBL] [Abstract][Full Text] [Related]
34. Prognostic value of triple-negative phenotype at the time of locally recurrent, conservatively treated breast cancer.
Parikh RR; Housman D; Yang Q; Toppmeyer D; Wilson LD; Haffty BG
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(4):1056-63. PubMed ID: 18676094
[TBL] [Abstract][Full Text] [Related]
35. Randomized phase 3 trial of fluorouracil, epirubicin, and cyclophosphamide alone or followed by Paclitaxel for early breast cancer.
Martín M; Rodríguez-Lescure A; Ruiz A; Alba E; Calvo L; Ruiz-Borrego M; Munárriz B; Rodríguez CA; Crespo C; de Alava E; López García-Asenjo JA; Guitián MD; Almenar S; González-Palacios JF; Vera F; Palacios J; Ramos M; Gracia Marco JM; Lluch A; Alvarez I; Seguí MA; Mayordomo JI; Antón A; Baena JM; Plazaola A; Modolell A; Pelegrí A; Mel JR; Aranda E; Adrover E; Alvarez JV; García Puche JL; Sánchez-Rovira P; Gonzalez S; López-Vega JM;
J Natl Cancer Inst; 2008 Jun; 100(11):805-14. PubMed ID: 18505968
[TBL] [Abstract][Full Text] [Related]
36. Clinical study of modified Ivor-Lewis esophagectomy plus adjuvant radiotherapy for local control of stage IIA squamous cell carcinoma in the mid-thoracic esophagus.
Chen G; Wang Z; Liu XY; Zhang MY; Liu FY
Eur J Cardiothorac Surg; 2009 Jan; 35(1):1-7. PubMed ID: 18926712
[TBL] [Abstract][Full Text] [Related]
37. Prediction of local recurrence, distant metastases, and death after breast-conserving therapy in early-stage invasive breast cancer using a five-biomarker panel.
Millar EK; Graham PH; O'Toole SA; McNeil CM; Browne L; Morey AL; Eggleton S; Beretov J; Theocharous C; Capp A; Nasser E; Kearsley JH; Delaney G; Papadatos G; Fox C; Sutherland RL
J Clin Oncol; 2009 Oct; 27(28):4701-8. PubMed ID: 19720911
[TBL] [Abstract][Full Text] [Related]
38. Preoperative chemotherapy is safe in early breast cancer, even after 10 years of follow-up; clinical and translational results from the EORTC trial 10902.
van Nes JG; Putter H; Julien JP; Tubiana-Hulin M; van de Vijver M; Bogaerts J; de Vos M; van de Velde CJ;
Breast Cancer Res Treat; 2009 May; 115(1):101-13. PubMed ID: 18484198
[TBL] [Abstract][Full Text] [Related]
39. Follicular thyroid carcinoma in an iodine-replete endemic goiter region: a prospectively collected, retrospectively analyzed clinical trial.
Asari R; Koperek O; Scheuba C; Riss P; Kaserer K; Hoffmann M; Niederle B
Ann Surg; 2009 Jun; 249(6):1023-31. PubMed ID: 19474675
[TBL] [Abstract][Full Text] [Related]
40. Radiotherapy after segmental resection of breast cancer with favorable prognostic features: 12-year follow-up results of a randomized trial.
Holli K; Hietanen P; Saaristo R; Huhtala H; Hakama M; Joensuu H
J Clin Oncol; 2009 Feb; 27(6):927-32. PubMed ID: 19114687
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
